Schistosoma Mansoni Worms Induce Anergy of T Cells Via Selective Up-regulation of Programmed Death Ligand 1 on Macrophages
Overview
Authors
Affiliations
Infectious pathogens can selectively stimulate activation or suppression of T cells to facilitate their survival within humans. In this study we demonstrate that the trematode parasite Schistosoma mansoni has evolved with two distinct mechanisms to suppress T cell activation. During the initial 4- to 12-wk acute stages of a worm infection both CD4(+) and CD8(+) T cells are anergized. In contrast, infection with male and female worms induced T cell anergy at 4 wk, which was replaced after egg laying by T cell suppression via a known NO-dependent mechanism, that was detected for up to 40 wk after infection. Worm-induced anergy was mediated by splenic F4/80(+) macrophages (Mphi) via an IL-4-, IL-13-, IL-10-, TGF-beta-, and NO-independent, but cell contact-dependent, mechanism. F4/80(+) Mphi isolated from worm-infected mice were shown to induce anergy of naive T cells in vitro. Furthermore, naive Mphi exposed to live worms in vitro also induced anergy in naive T cells. Flow cytometry on in vivo and in vitro worm-modulated Mphi revealed that of the family of B7 costimulatory molecules, only programmed death ligand 1 (PD-L1) was selectively up-regulated. The addition of inhibitory mAb against PD-L1, but not PD-L2, to worm-modulated Mphi completely blocked the ability of these cells to anergize T cells. These data highlight a novel mechanism through which S. mansoni worms have usurped the natural function of PD-L1 to reduce T cell activation during early acute stages of infection before the subsequent emergence of egg-induced T cell suppression in the chronic stages of infection.
Helminth extracellular vesicles co-opt host monocytes to drive T cell anergy.
Borup A, Sharifpour M, Rossen L, Whitehead B, Boysen A, Olesen R J Extracell Vesicles. 2025; 14(1):e70027.
PMID: 39815783 PMC: 11735955. DOI: 10.1002/jev2.70027.
RNA-seq gene expression profiling of the bladder in a mouse model of urogenital schistosomiasis.
Ishida K, Osakunor D, Rossi M, Lamanna O, Mbanefo E, Cody J bioRxiv. 2024; .
PMID: 38979184 PMC: 11230422. DOI: 10.1101/2024.06.29.601185.
Grezzi L, Martinez Y, Barrios A, Diaz A, Casaravilla C Infect Immun. 2024; 92(2):e0027623.
PMID: 38174942 PMC: 10863420. DOI: 10.1128/iai.00276-23.
Bischofsberger M, Reinholdt C, Dannenhaus T, Aleith J, Bergmann-Ewert W, Muller-Hilke B Pathogens. 2023; 12(12).
PMID: 38133315 PMC: 10746046. DOI: 10.3390/pathogens12121432.
Cavallone I, Belda Jr W, de Carvalho C, Laurenti M, Passero L J Fungi (Basel). 2023; 9(12).
PMID: 38132773 PMC: 10744586. DOI: 10.3390/jof9121172.